Status:
COMPLETED
The Fever and Antipyretic in Critically Illness Evaluation Study
Lead Sponsor:
Japanese Society of Intensive Care Medicine
Conditions:
Fever
Hyperthermia
Eligibility:
All Genders
20+ years
Brief Summary
The purpose of this multination multicenter observational study is to determine the impact of fever and antipyretic on outcomes in critically ill patients.
Detailed Description
Fever is common in critically ill patients.Antipyretic therapy for fever is routinely performed in intensive care.There are studies to assess the relationship between fever and mortality in non-neurol...
Eligibility Criteria
Inclusion
- Adult non-neurological critically ill patients (20 years old or older).
- ICU patients expected to require intensive care for more than 48 hour.
Exclusion
- Patients with brain injury (suspected or proven)
Key Trial Info
Start Date :
September 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2009
Estimated Enrollment :
1426 Patients enrolled
Trial Details
Trial ID
NCT00940654
Start Date
September 1 2009
End Date
December 1 2009
Last Update
May 19 2010
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
The Japanese Society of Intensive Care Medicine
Bunkyo-ku, Tokyo, Japan, 113-0033
2
Korean Society of Critical Care Medicine
Songpa-gu, Seoul, South Korea, 138-736